MF

Mary Lee Fleishell

Sr. Director Contracts & Intellectual Property at C4 Therapeutics

Mary Lee Fleishell has extensive experience in business development and intellectual property management consulting services in the biotechnology industry. Mary Lee has held various roles in different companies such as C4 Therapeutics, Astellas Institute of Regenerative Medicine, Ziopharm Oncology, and Curis. Mary Lee holds a Bachelor of Arts degree in Biochemistry from Wellesley College.

Links

Previous companies

Curis logo
Alnylam Pharmaceuticals logo

Org chart

Peers

Mayra Reyes-Armour

VP, Technical Operations

Stew Fisher

Chief Scientific Officer

Scott Boyle

Chief Business Officer

Timeline

  • Sr. Director Contracts & Intellectual Property

    September, 2020 - present

  • Director Contracts Intellectual Property

    January, 2017

  • Business Development Consultant

    March, 2016

View in org chart